Poorer Neuropsychological Test Scores for HIV-Positive

Share this content:
Poorer Neuropsychological Test Scores for HIV-Positive
Poorer Neuropsychological Test Scores for HIV-Positive

WEDNESDAY, Nov. 15, 2017 (HealthDay News) -- HIV-positive individuals treated with combination antiretroviral therapy (cART) have poorer neuropsychological test scores than controls but no significant neuropsychological decline over time, according to a study published online Nov. 13 in JAMA Neurology.

Ryan Sanford, from McGill University in Canada, and colleagues conducted neuroimaging and neuropsychological assessments approximately two years apart among individuals in a case-control study. Data were included for 48 HIV-positive individuals who were aviremic and treated with cART and 31 demographically similar HIV-negative controls.

The researchers found that after adjustment for age, sex, and educational level, HIV-positive participants had poorer neuropsychological test scores on the Trail Making Test Part A (5.9 seconds), Trail Making Test Part B (27.3 seconds), Digit Symbol Substitution Task (−12.5 marks), Letter-Number Sequencing (−2.5 marks), Letter Fluency (−6.6 words), and Hopkins Verbal Learning Test-Revised immediate recall (−2.4 words) compared with controls. Between the groups, the only significant difference was seen in changes in Trail Making Test Part A. Compared with controls, HIV-positive individuals had smaller cortical thickness and subcortical volumes. Over time the changes in brain volume were similar between the groups.

"These findings support the hypothesis that brain injury due to HIV could occur principally during untreated infection," the authors write. "This finding suggests that early initiation of cART and full viral suppression may preserve long-term brain health."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Meds for Opioid Use Disorder May Reduce Mortality in OD Survivors

Meds for Opioid Use Disorder May Reduce Mortality ...

Minority of opioid overdose survivors receive MOUD; buprenorphine, MMT linked to reduced mortality

Pharmacists Are Well Placed to Improve Adult Vaccination Rates

Pharmacists Are Well Placed to Improve Adult Vaccination ...

Pharmacies can address cost barriers to vaccination by providing vaccines at lower cost

Single Blood Sample Test May Help ID Undiagnosed Diabetes

Single Blood Sample Test May Help ID Undiagnosed ...

Single-sample confirmatory definition associated with high positive predictive value

is free, fast, and customized just for you!




Already a member?

Sign In Now »